Hepatocellular Carcinoma

February 10th, 2023 - February 10th, 2026
1.00 AMA PRA Category 1 Credit Hours
1.00 MOC Points


Today on MedNet21, we're going to discuss Hepatocellular Carcinoma. Discuss growing significant of liver cancer and its management.

View Webcast Take Post-Test

Dates and Times

End Date: 2/10/2026


As a result of this educational activity, webcast participants will be able to:

  • Recognize the increasing incidence of liver cancer
  • Recognize the importance of screening and introduce different treatment options available

Webcasts Files

File Link

Hepatocellular Carcinoma - 2


Hepatocellular Carcinoma - 4


Hepatocellular Carcinoma - 2 - color


Disclosure Information for Planning Committee Members and Speakers



  • Dr. Lanla Conteh, MD
    • Hepatocellular Carcinoma


The Center for Continuing Medical Education (CCME) at The Ohio State University is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians

The Center for Continuing Medical Education (CCME) at The Ohio State University designates this webcasts for a maximum of 1.00 AMA PRA Category 1 Credit(s) . Physicians should only claim credit commensurate with the extent of their participation in the activity.

Maintenance of Certification

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.00 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.